Home › Free Stock Grades › CAMP
CAMP4 Therapeutics Corporation (CAMP) Stock Grade
CAMP · Healthcare
C
Market Cap
$81.8M
P/E Ratio
—
Revenue Growth (YoY)
+436.5%
Net Margin
-2298.5%
Return on Equity
—
Dividend Yield
None
About CAMP4 Therapeutics Corporation's fundamentals
CAMP4 Therapeutics is a small-cap biotechnology company with a market capitalization of $81.8 million that reported exceptional revenue growth of 436.5% year-over-year, indicating rapidly expanding commercial activity. However, the company operates at a significant loss, with a net margin of -2298.5%, meaning expenses far exceed revenues by a substantial margin. The company does not pay a dividend and reported a net loss in its latest annual statement, which is typical for early-stage biotech firms investing heavily in research and development and commercialization efforts.